Joseph Rubin

Joseph Rubin is a medical oncologist with expertise in appendiceal neoplasms and pseudomyxoma peritonei who has contributed to clinical studies defining the natural history, systemic therapy options, and optimal management pathways for patients with appendiceal mucinous adenocarcinoma and low-grade appendiceal mucinous neoplasm (LAMN). His research has examined whether systemic chemotherapy adds benefit to CRS-HIPEC in appendiceal cancer and has investigated the distinct biology of goblet cell carcinoid (GCA), a hybrid adenocarcinoma-carcinoid tumor requiring different treatment than pure carcinoid.